Insilico prediction of anticancer cyanobacterial drug from Nostoc

M. Sangeetha, M. Menakha, S. Vijayakumar
{"title":"Insilico prediction of anticancer cyanobacterial drug from Nostoc","authors":"M. Sangeetha,&nbsp;M. Menakha,&nbsp;S. Vijayakumar","doi":"10.1016/j.bionut.2013.08.008","DOIUrl":null,"url":null,"abstract":"<div><p><span>The aim of the present study was to predict the anticancer drug<span> from the members of the cyanobacteria. </span></span><span><em>In silico</em></span><span> molecular docking<span> was carried out between the cyanobacterial drug, cryptophycin-F and different types of cancer target proteins. Molecular docking also helped to compare the commercial drug, cabazitaxel with cyanobacterial drug, cryptophycin-F. The energy values produced by the cryptophycin-F with various cancer receptor molecules were ranging from −</span></span> <!-->259.14 to −<!--> <!-->330.01 while, cabazitaxel showed −<!--> <!-->228.18 to −<!--> <!-->385.32. From the above results, it is concluded that cabazitaxel and cryptophycin-F produced more or less similar docking energy with cancer receptor molecules. Therefore, cryptophycin-F, a cyanobacterial drug can be employed as an alternative drug for treating various cancers without any side effects.</p></div>","PeriodicalId":100182,"journal":{"name":"Biomedicine & Preventive Nutrition","volume":"4 1","pages":"Pages 71-73"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.bionut.2013.08.008","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedicine & Preventive Nutrition","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210523913000548","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The aim of the present study was to predict the anticancer drug from the members of the cyanobacteria. In silico molecular docking was carried out between the cyanobacterial drug, cryptophycin-F and different types of cancer target proteins. Molecular docking also helped to compare the commercial drug, cabazitaxel with cyanobacterial drug, cryptophycin-F. The energy values produced by the cryptophycin-F with various cancer receptor molecules were ranging from − 259.14 to − 330.01 while, cabazitaxel showed − 228.18 to − 385.32. From the above results, it is concluded that cabazitaxel and cryptophycin-F produced more or less similar docking energy with cancer receptor molecules. Therefore, cryptophycin-F, a cyanobacterial drug can be employed as an alternative drug for treating various cancers without any side effects.

来自Nostoc的抗癌蓝藻药物的计算机预测
本研究的目的是预测从蓝藻成员的抗癌药物。蓝藻药物隐藻素- f与不同类型的肿瘤靶蛋白进行了硅分子对接。分子对接也有助于比较商业药物卡巴他赛和蓝藻药物隐藻素f。隐藻素- f与不同肿瘤受体分子产生的能量值为−259.14 ~−330.01,而卡巴他赛产生的能量值为−228.18 ~−385.32。从以上结果可以看出,卡巴他赛和隐藻素- f与癌症受体分子的对接能量或多或少相似。因此,蓝藻药物隐藻素f可以作为治疗各种癌症的替代药物,而且没有任何副作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信